OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ANGM.MZ54

Swan Life Ltd

Life & Health InsuranceVerified

Swan Life Ltd has a basic capital structure with 2,632,210 shares outstanding, both basic and diluted, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and returns data are not available for Swan Life Ltd, as no financial metrics such as ROIC, EBITDA margins, or net profit margins are provided in the valuation snapshot. This lack of data makes it difficult to compare the company's performance against industry_config preferred metrics or cohort medians. Segment and geographic exposure details are not disclosed in the available data, making it impossible to assess revenue concentration or geographic diversification. Growth trajectory data is also not available, as no numeric deltas or revenue history are provided in the outlook section. This limits the ability to evaluate the company's current and future growth prospects. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, as there is no evidence of dilution from stock options or convertible instruments. Recent events or filings are not disclosed in the available data, so no specific recent developments can be reported.

30-day price · ANGM.MZ-30.00 (-2.1%)
Low$1395.00High$1425.00Close$1395.00As of29 May, 00:00 UTC
Profile
CompanySwan Life Ltd
TickerANGM.MZ
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Swan Life Ltd is a life and health insurance provider operating in the Financials sector, offering insurance products and services to its clients.

Classification. Swan Life Ltd is classified under the Life & Health Insurance industry within the Insurance business sector, with a classification confidence of 0.92.

Swan Life Ltd has a basic capital structure with 2,632,210 shares outstanding, both basic and diluted, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and returns data are not available for Swan Life Ltd, as no financial metrics such as ROIC, EBITDA margins, or net profit margins are provided in the valuation snapshot. This lack of data makes it difficult to compare the company's performance against industry_config preferred metrics or cohort medians. Segment and geographic exposure details are not disclosed in the available data, making it impossible to assess revenue concentration or geographic diversification. Growth trajectory data is also not available, as no numeric deltas or revenue history are provided in the outlook section. This limits the ability to evaluate the company's current and future growth prospects. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, as there is no evidence of dilution from stock options or convertible instruments. Recent events or filings are not disclosed in the available data, so no specific recent developments can be reported.
Key takeaways
  • Swan Life Ltd has a basic capital structure with no dilution from stock options or convertible securities.
  • Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
  • Profitability and returns data are not available, making it difficult to compare the company's performance against industry benchmarks.
  • Segment and geographic exposure details are not disclosed, limiting the ability to assess revenue concentration or geographic diversification.
  • Growth trajectory data is not available, as no numeric deltas or revenue history are provided in the outlook section.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMUR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$3.35B$517.7M$407.3M
FY-3$3.62B$575.1M$497.7M
FY-2$583.7M$507.2M$407.6M
FY-1$782.3M$623.1M$518.2M
FY0$836.3M$686.2M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$48.43B$1.59B$1.94B
FY-3$56.67B$2.03B$1.45B
FY-2$54.29B$3.28B
FY-1$60.97B$3.75B
FY0$71.23B$4.57B
PeriodOCFCapExFCFSBC
FY-4$1.89B-$35.0M$407.3M
FY-3$2.37B-$11.7M$497.7M
FY-2$2.06B-$15.9M$407.6M
FY-1$3.01B-$28.4M$518.2M
FY0$5.12B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6$312.8M$260.4M
FQ-5$156.2M$122.1M
FQ-4$247.4M$213.9M
FQ-3
FQ-2$139.3M$108.3M
FQ-1$232.2M$190.1M
FQ0$241.5M$195.9M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6$63.92B$4.09B
FQ-5$65.06B$4.23B
FQ-4$67.41B$4.50B
FQ-3$71.23B$4.57B
FQ-2$69.58B$4.42B
FQ-1$71.24B$4.62B
FQ0$73.92B$4.83B
PeriodOCFCapExFCFSBC
FQ-7
FQ-6$1.32B
FQ-5$3.24B
FQ-4$3.91B
FQ-3$5.12B
FQ-2$142.4M
FQ-1$290.1M
FQ0$1.41B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricANGM.MZActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity27.5% medp25 4.7% · p75 66.5%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:37 UTC#a7627778
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 08:55 UTCJob: a5db1f6d